$SCMP Headlines Sucampo Pharma rises 7.9% in pre

$SCMP Headlines

Sucampo Pharma rises 7.9% in premarket 9:18 a.m. Dec. 12, 2012 - Steve Gelsi
Sucampo gets nod for glaucoma drug from FDA 8:07 a.m. Dec. 12, 2012 - MarketWatch.com
Wednesday’s biggest gaining and declining stocks 1:47 p.m. Sept. 26, 2012 - Greg Morcroft
FDA grants priority review for Sucampo's Amitiza 7:45 a.m. Sept. 26, 2012 - MarketWatch.com
Ironwood pins hopes on Linaclotid 10:37 a.m. Aug. 16, 2011 - MarketWatch.com
Sucampo, Abbott file in Japan on constipation drug 2:51 a.m. Oct. 7, 2010 - Robert Daniel

Galectin Therapeutics (GALT) in Focus: Stock Moves Up 13.2% - Tale of the Tape 8:57 a.m. Dec. 4, 2013 - Zacks.com
Strength Seen in Lannett Company (LCI): Stock Gains 8.7% - Tale of the Tape 8:30 a.m. Dec. 3, 2013 - Zacks.com
Enanta Pharmaceuticals (ENTA) Looks Good: Stock Adds 6.2% - Tale of the Tape 8:30 a.m. Nov. 26, 2013 - Zacks.com
Strength Seen in Ariad Pharmaceuticals (ARIA): Stock Zooms 35.5% - Tale of the Tape 9:39 a.m. Nov. 25, 2013 - Zacks.com
Dynavax Technologies (DVAX) in Focus: Stock Moves 5.8% Higher - Tale of the Tape 9:18 a.m. Nov. 20, 2013 - Zacks.com
Prescription for Profit - Zacks Industry Rank Analysis 12:33 p.m. Nov. 19, 2013 - Zacks.com
Ohr Pharmaceutical (OHRP) Looks Good: Stock Jumps 7.4% - Tale of the Tape 9:25 a.m. Nov. 12, 2013 - Zacks.com
10-Q: SUCAMPO PHARMACEUTICALS, INC. 11:36 a.m. Nov. 8, 2013 - Edgar Online - (EDG = 10Q, 10K)
Sucampo Pharmaceuticals' CEO Discusses Q3 2013 Results - Earnings Call Transcript 12:37 a.m. Nov. 6, 2013 - Seeking Alpha
Sucampo Pharmaceuticals, Inc. Discusses Q3 2013 Results (Webcast) 4:55 p.m. Nov. 5, 2013 - Seeking Alpha
Sucampo Progresses on Amitiza - Analyst Blog 6:08 p.m. Oct. 25, 2013 - Zacks.com
Sucampo, Takeda Initiate Pivotal Trial of Lubiprostone Liquid Formulation 4:55 a.m. Oct. 23, 2013 - benzinga.com
Sucampo Completes Patient Enrollment in Phase 3 Clinical Study of Unoprostone Isopropyl for Retinitis Pigmentosa 8:43 p.m. Oct. 21, 2013 - benzinga.com
Weekly CEO Sells Highlight: Sucampo Pharmaceuticals Inc, Family Dollar Stores Inc, Nike Inc, ... 11:25 a.m. Oct. 21, 2013 - GuruFocus.com
Sucampo Presentats Results on Lubiprostone in Pediatric Functional Constipation at NASPGHAN 2013 3:58 a.m. Oct. 11, 2013 - benzinga.com
Positive Data on Sucampo's Amitiza - Analyst Blog 1:45 p.m. Oct. 9, 2013 - Zacks.com
Update on Progenics Pharma's Relistor - Analyst Blog 6:30 p.m. Oct. 3, 2013 - Zacks.com
Salix Pharmaceuticals: Why You Shouldn't Be Dumping This Stock? 1:32 p.m. Aug. 29, 2013 - Seeking Alpha
Sucampo Pharmaceuticals' CEO Discusses Q2 2013 Results - Earnings Call Transcript 9:13 p.m. Aug. 8, 2013 - Seeking Alpha
Sucampo Announces Positive Results of Phase 1a Cobiprostone and SPI-3608 Trials 8:10 p.m. Aug. 7, 2013 - benzinga.com


Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2013 Credit Suisse Healthcare Conference 6:45 a.m. Nov. 6, 2013 - GlobeNewswire
Sucampo Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2013 Financial and Operating Results 4:05 p.m. Nov. 5, 2013 - GlobeNewswire
Numab Reacquires Advanced Compound from Sucampo 7:00 a.m. Oct. 29, 2013 - BusinessWire
Sucampo and Takeda Initiate Pivotal Trial of Lubiprostone Liquid Formulation in Adults With Chronic Idiopathic Constipation 5:45 a.m. Oct. 23, 2013 - GlobeNewswire
Sucampo Pharmaceuticals Announces Third Quarter and Nine Months 2013 Results and Operating Highlights Teleconference and Webcast 7:00 p.m. Oct. 22, 2013 - GlobeNewswire
Sucampo Announces Completion of Patient Enrollment in a Phase 3 Clinical Study of Unoprostone Isopropyl for Retinitis Pigmentosa 7:00 p.m. Oct. 21, 2013 - GlobeNewswire
Sucampo Announces Presentation of Results on AMITIZA(R) (lubiprostone) in Opioid-Induced Constipation at Two Upcoming Scientific Conferences 5:45 a.m. Oct. 11, 2013 - GlobeNewswire
Sucampo Announces Presentation of Results on Lubiprostone in Pediatric Functional Constipation at NASPGHAN 2013 7:00 p.m. Oct. 10, 2013 - GlobeNewswire
Clinical Data Show That Lubiprostone is Efficacious and Well Tolerated in Children and Adolescents With Functional Constipation 5:45 a.m. Oct. 8, 2013 - GlobeNewswire
Sucampo to Present Data on AMITIZA(R) (Lubiprostone) in Opioid-Induced Constipation at 24th Annual AAPM Meeting 5:45 a.m. Sept. 27, 2013 - GlobeNewswire
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at BioCentury(R) NewsMakers in the Biotech Industry 2013 Conference 5:45 a.m. Sept. 20, 2013 - GlobeNewswire
Sucampo to Present Data on AMITIZA(R) (lubiprostone) in Chronic Idiopathic Constipation at Annual Meeting of the Swiss Society of Gastroenterology 6:00 p.m. Sept. 12, 2013 - GlobeNewswire
Sucampo to Present Results From Four Phase 3 Studies of AMITIZA(R) (lubiprostone) for Opioid-Induced Constipation at PAINWeek 2013 7:05 p.m. Sept. 4, 2013 - GlobeNewswire
RDInvesting Provides Investors with Free In-Depth Equity Reports on BDE, ESV, SCMP and WSM 7:42 a.m. Sept. 4, 2013 - ACCESSWIRE
Sucampo Begins Search for New CEO 3:02 p.m. Aug. 8, 2013 - GlobeNewswire
Sucampo Pharmaceuticals, Inc. Reports Second Quarter and Six Months 2013 Financial and Operating Results 3:02 p.m. Aug. 8, 2013 - GlobeNewswire
Sucampo Announces Positive Top-Line Results in Phase 1a Trials of Cobiprostone and SPI-3608 7:02 p.m. Aug. 7, 2013 - GlobeNewswire
Sucampo Pharmaceuticals Announces Second Quarter and Six Months 2013 Results and Operating Highlights Teleconference and Webcast 5:45 a.m. July 25, 2013 - GlobeNewswire
Sucampo Receives $10 Million Milestone Payment from Takeda on First Sale of AMITIZA(R) (lubiprostone) for OIC in the US 7:02 p.m. June 26, 2013 - BusinessWire
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Jefferies 2013 Global Healthcare Conference 5:45 a.m. May 30, 2013 - BusinessWire